Predictions
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€11.50
21.03.21
21.03.21
-
21.03.22
21.03.22
-64.30%
22.03.22
22.03.22
Could be very worthwhile Investment >20% year
Innovative
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€9.83
21.03.21
21.03.21
-
21.03.22
21.03.22
-26.45%
22.03.22
22.03.22
Could be worthwhile Investment >10% per year
Capable Management
Known brand
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€6.14
20.03.21
20.03.21
€3.00
20.03.22
20.03.22
-1.27%
03.04.21
03.04.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Aphria Inc.
Start price
Target price
Perf. (%)
€16.47
19.03.21
19.03.21
€13.00
19.03.22
19.03.22
-22.87%
20.02.22
20.02.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Johnson & Johnson
Start price
Target price
Perf. (%)
€135.56
16.03.21
16.03.21
€140.00
-0.53%
23.03.21
23.03.21
Known brand
Future proof or reliable business model
Medium risks for its business
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.35
15.03.21
15.03.21
€50.00
15.03.22
15.03.22
43.43%
09.11.21
09.11.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Acer Therapeutics Inc
Start price
Target price
Perf. (%)
€5.50
15.03.21
15.03.21
-
-48.36%
18.03.21
18.03.21
Risky Investment
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€3.74
13.03.21
13.03.21
-
13.03.22
13.03.22
-56.95%
08.12.21
08.12.21
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€9.66
13.03.21
13.03.21
-
13.03.22
13.03.22
-75.14%
13.03.22
13.03.22
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€59.31
13.03.21
13.03.21
-
13.03.22
13.03.22
-80.85%
13.03.22
13.03.22
Nanorepro AG
Start price
Target price
Perf. (%)
€16.00
12.03.21
12.03.21
€22.00
12.03.22
12.03.22
-62.19%
12.08.21
12.08.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€13.28
12.03.21
12.03.21
€24.00
12.03.22
12.03.22
-62.26%
12.03.22
12.03.22
Could be very worthwhile Investment >20% year
Hepion Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€38.20
11.03.21
11.03.21
€60.00
11.03.22
11.03.22
-47.98%
12.03.22
12.03.22
.png?locale=us "FinanceClub_UoM")